Agonists By Bright Minds, A Biotechnology Company, Opens New Gateways To Healing The Mind
Link Title
Link Short URL
Link Long URL
Description:
The year 2021 marked the beginning of psychedelic researches in public, as many biotechnology companies emerged as active players in this industry. Research organizations, such as Bright Minds Biosciences, a biotechnology company, raised above $2000 million for their research projects. The use of psychedelics has been tabooed since 1960 because the US included almost every psychoactive drug as a schedule I drug and put a ban on its use.
Keywords (Tags):
Created by:
Bright Minds Biosciences
Created on:
Hits:
491
|